RIXIMYO
Live / Registered — Registered (as of 06 Jul 2021)
What this means for you
Registered since 06 Jul 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90003675
- Registration number
- 6406935
- Mark type
- Stylized text
- Filed
- 16 Jun 2020
- Published for opposition
- 20 Apr 2021
- Registered
- 06 Jul 2021
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the prevention and treatment of immune system disorders, for use in oncology, and for use in tissue and organ transplantation
Owner
- SANDOZ AG, BASEL, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 06 Dec 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Jul 2021 — REGISTERED-PRINCIPAL REGISTER
- 20 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Apr 2021 — PUBLISHED FOR OPPOSITION
- 31 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2021 — EXAMINER'S AMENDMENT ENTERED
- 17 Mar 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2021 — EXAMINERS AMENDMENT E-MAILED
- 17 Mar 2021 — EXAMINERS AMENDMENT -WRITTEN
- 16 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Sept 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Sept 2020 — NON-FINAL ACTION E-MAILED